// App-Quantinova.ai

304 : Prognostic influence of clinical biomarkers in patients (pts) with advanced hepatocellular carcinoma (HCC) receiving sorafenib: A single institution experience.

Researchers

Presenter

  • Omar Abdel-Rahman

Principal Investigators

  • Angela Lamarca

  • Ismail Salu

  • Mairead G McNamara

  • Juan W. Valle

  • Richard Hubner

Medical Centers

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • The Christie NHS Foundation TRUST, Manchester, United Kingdom

  • The Christie NHS Foundation Trust and University of Manchester, Manchester, United Kingdom

  • University of Manchester, The Christie Hospital NHS Foundation Trust, Manchester, United Kingdom

  • The Christie Hospital, Manchester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Liver cancer

Biomarkers

  • N/A

Drug/Treatment

  • Sorafenib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved